Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Movement Disorders

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.27323PMID 29488270PMCID PMC12570294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Performance Assessment of Self-Care Skills (PASS)

  2019cited by this paper
• Mild Cognitive Impairment in Parkinson’s Disease—What Is It?

  2018cited by this paper
• Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease

  2018cited by this paper
• Reader response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB consortium

  2018cited by this paper
• An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease

  2018cited by this paper
• Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

  2017cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2017cited by this paper
• Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer’s Disease: A Comparison of the Cognitive and Clinical Profiles

  2017influential reference
• The New Diagnostic Criteria for Parkinson's Disease.

  2017cited by this paper
• Mild cognitive impairment as a risk factor for Parkinson's disease dementia

  2017influential reference
• A Bayesian mathematical model of motor and cognitive outcomes in Parkinson’s disease

  2017cited by this paper
• Natural course of mild cognitive impairment in Parkinson disease

  2017cited by this paper
• Trajectories of prediagnostic functioning in Parkinson’s disease

  2017cited by this paper
• Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms

  2017cited by this paper
• Stability of mild cognitive impairment in newly diagnosed Parkinson's disease

  2017cited by this paper
• Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire

  2016influential reference
• Mild cognitive impairment in Parkinson’s disease: Diagnosis and progression to dementia

  2016cited by this paper
• UCSD Performance-Based Skills Assessment

  2016cited by this paper
• Cognitive decline in Parkinson’s disease: the complex picture

  2016cited by this paper
• Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study

  2016cited by this paper
• Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.

  2016cited by this paper
• Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

  2016cited by this paper
• Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease

  2016cited by this paper
• Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo‐controlled trial

  2016cited by this paper
• The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson’s Disease

  2016cited by this paper
• The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease.

  2016influential reference
• Revisiting DLB Diagnosis

  2016cited by this paper
• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

  2016influential reference
• Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

  2016cited by this paper
• MDS research criteria for prodromal Parkinson's disease

  2015cited by this paper
• Diagnosing PD‐MCI by MDS task force criteria: How many and which neuropsychological tests?

  2015cited by this paper
• Mild Cognitive Impairment in Early Parkinson's Disease Using the Movement Disorder Society Task Force Criteria: Cross-Sectional Study in Hoehn and Yahr Stage 1

  2015cited by this paper
• Advances in the treatment of cognitive impairment in Parkinson's disease

  2015cited by this paper
• Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

  2015cited by this paper
• Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

  2015cited by this paper
• Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.

  2015cited by this paper
• Cognitive function in the early phase of Parkinson's disease, a five‐year follow‐up

  2015cited by this paper
• Clinical Characterization of Mild Cognitive Impairment as a Prodrome to Dementia With Lewy Bodies

  2015cited by this paper
• MDS clinical diagnostic criteria for Parkinson's disease

  2015cited by this paper
• Quality of Life and Mild Cognitive Impairment in Early Parkinson’s Disease: Does Subtype Matter?

  2014cited by this paper
• Characterizing mild cognitive impairment in incident Parkinson disease

  2014cited by this paper
• APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

  2014cited by this paper
• Harmonized diagnostic criteria for Alzheimer's disease: recommendations

  2014cited by this paper
• Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.

  2014cited by this paper
• Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.

  2014cited by this paper
• Instrumental activities of daily living performance among people with Parkinson's disease without dementia.

  2014influential reference
• Evaluation of mild cognitive impairment subtypes in Parkinson's disease

  2014cited by this paper
• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

  2014cited by this paper
• Evolution of mild cognitive impairment in Parkinson disease

  2013cited by this paper
• Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease

  2013cited by this paper
• Measuring mild cognitive impairment in patients with Parkinson's disease

  2013influential reference
• Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s disease

  2013cited by this paper
• Bacchus by Caravaggio as the Visual Diagnosis of Alcohol Use Disorder from the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

  2013cited by this paper
• Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

  2013cited by this paper
• Mild cognitive impairment in Parkinson's disease.

  2013cited by this paper
• Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies

  2013influential reference
• Comparison of activities of daily living impairments in Parkinson's disease patients as defined by the Pill Questionnaire and assessments by neurologists

  2013cited by this paper
• Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.

  2013cited by this paper
• Clinical differences among mild cognitive impairment subtypes in Parkinson's disease

  2012cited by this paper
• Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis

  2012cited by this paper
• Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia

  2012cited by this paper
• Retrospective Survey of Prodromal Symptoms in Dementia with Lewy Bodies: Comparison with Alzheimer’s Disease

  2012cited by this paper
• Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience.

  2012cited by this paper
• Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

  2012cited by this paper
• Neuropsychological assessment, 5th ed.

  2012cited by this paper
• Lower cognitive performance in healthy G2019S LRRK2 mutation carriers

  2012cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Evidence for ordering of Alzheimer disease biomarkers.

  2011cited by this paper
• MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI

  2011cited by this paper
• Mild cognitive impairment in Parkinson's disease.

  2011cited by this paper
• Parkinson's disease: The quintessential neuropsychiatric disorder

  2011cited by this paper
• Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease.

  2010cited by this paper
• Association between cognition and function in patients with Parkinson disease with and without dementia

  2010cited by this paper
• Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics.

  2010cited by this paper
• Mild cognitive impairment in Parkinson disease

  2010cited by this paper
• Mild cognitive impairment: ten years later.

  2009cited by this paper
• Cognitive impairment in incident, untreated Parkinson disease

  2009cited by this paper
• The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

  2009cited by this paper
• Parkinson's disease‐cognitive rating scale: A new cognitive scale specific for Parkinson's disease

  2008cited by this paper
• Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

  2007cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

  2007cited by this paper
• Cognitive impairment in Parkinson’s disease

  2007cited by this paper
• Implications of within-person variability in cognitive and neuropsychological functioning for the interpretation of change.

  2007cited by this paper
• Subjective report versus objective measurement of activities of daily living in Parkinson's disease

  2006cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• Ideational apraxia

  2004cited by this paper
• Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

  2004cited by this paper
• Mild cognitive impairment as a diagnostic entity

  2004cited by this paper
• The rate of cognitive decline in Parkinson disease.

  2004cited by this paper
• Neuropathology of Cognitively Normal Elderly

  2003cited by this paper
• Caregivers' judgments of the functional abilities of the Alzheimer's disease patient: a comparison of proxy reports and objective measures.

  2001cited by this paper
• UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

  2001cited by this paper
• Current concepts in mild cognitive impairment.

  2001influential reference
• Caregivers' Judgments of the Functional Abilities of the Alzheimer's Disease Patient: Impact of Caregivers' Depression and Perceived Burden

  2001cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• [Dementia rating scale].

  1997cited by this paper
• Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.

  1993cited by this paper
• [Cognitive impairment in Parkinson's disease].

  1991cited by this paper
• Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

  1991cited by this paper

• Understanding Cognitive Domains in Parkinson's Disease: A Scoping Review of Empirical Studies.

  2026cites this paper
• Effects of high-frequency repetitive transcranial magnetic stimulation over left dorsolateral prefrontal cortex on mild cognitive impairment of Parkinson's disease: a double-blind randomized sham-controlled trial.

  2026cites this paper
• Language impairment as a risk factor for dementia conversion in parkinson's disease with mild cognitive impairment: a quantitative EEG study.

  2026cites this paper
• Tryptophan-kynurenine metabolism: A link between the gut microbiota dysbiosis and cognitive impairment.

  2026cites this paper
• Diagnostic classification of mild cognitive impairment in Parkinson's disease using subject-level stratified machine-learning analysis

  2025cites this paper
• Cognitive Fluctuation Scale in Non‐demented Patients with Parkinson's Disease

  2025cites this paper
• Parkinson-Krankheit – nicht-motorische Symptome für die Praxis

  2025cites this paper
• Co-exposure to polycyclic aromatic hydrocarbons and nicotine and their associations with cognitive impairment risk in older adults from southern China.

  2025cites this paper
• Managing cognitive impairment in Parkinson’s disease: an update of the literature

  2025cites this paper
• Ganoderma lucidum polysaccharides target the gut-brain axis: Unveiling a novel mechanism for ameliorating aging-induced cognitive impairment and oxidative stress.

  2025cites this paper
• Subitem-level multi-scale assessment and machine learning for three-class cognitive status classification in Parkinson’s disease

  2025cites this paper
• Cholinergic network disruptions on cognitive function across the spectrum of cognitive impairment in Parkinson’s disease

  2025cites this paper
• Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease

  2024cites this paper
• Subjective Cognitive Complaints in Parkinson's Disease: A Systematic Review and Meta‐Analysis

  2024cites this paper
• Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects

  2024cites this paper
• Cognitive disorders in Parkinson's disease

  2024cites this paper
• Association of plasma homocysteine with cognitive impairment in patients with Parkinson’s disease

  2024cites this paper
• Increased dementia risk in patients with Parkinson’s disease attributed to metabolic syndrome

  2024cites this paper
• Optimal MMSE and MoCA cutoffs for cognitive diagnoses in Parkinson's disease: A data-driven decision tree model.

  2024cites this paper
• Comorbidity of white matter lesions in parkinson’s disease: a study on risk factors and phenotypic differences

  2024cites this paper
• Polygonatum sibiricum polysaccharide regulation of gut microbiota: A viable approach to alleviate cognitive impairment.

  2024cites this paper
• Fractional Anisotropy is a More Sensitive Diagnostic Biomarker Than Mean Kurtosis for Patients with Parkinson Disease with Cognitive Dysfunction: A Diffusional Kurtosis Map Tract-Based Spatial Statistics Study

  2024cites this paper
• Polygonum minus: A tropical medicinal herb with vast applications in food, agricultural, and medicinal fields

  2024cites this paper
• Mediation of White Matter Alterations in the Association Between Ventricular Dilation and Cognitive Decline in Hydrocephalus Patients: An MRI Study

  2024cites this paper
• Neurocognitive Impairment and Social Cognition in Parkinson’s Disease Patients

  2024influential citation
• Spontaneous brain activity in the hippocampal regions could characterize cognitive impairment in patients with Parkinson's disease

  2024cites this paper
• Memory Phenotypes In Early, De Novo Parkinson's Disease Patients with Mild Cognitive Impairment

  2023cites this paper
• Mild cognitive impairment in patients with Parkinson´s disease and the analysis of associated factors

  2023influential citation
• Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study

  2023cites this paper
• Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease

  2023cites this paper
• Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease

  2022cites this paper
• Plant polysaccharides utilized by gut microbiota: New players in ameliorating cognitive impairment

  2022cites this paper
• Capturing Subjective Mild Cognitive Decline in Parkinson’s Disease

  2022influential citation
• Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease.

  2022cites this paper
• Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype

  2022cites this paper
• Urinary polycyclic aromatic hydrocarbon metabolites, plasma p-tau231 and mild cognitive impairment in coke oven workers.

  2022cites this paper
• Mild cognitive impairment in patients with Parkinson’s disease: An updated mini-review and future outlook

  2022cites this paper
• A comprehensive decoding of cognitive load

  2022cites this paper
• The Effect of Highly Challenging Balance Training on Balance in Parkinson's Sufferers: Critical Review

  2022cites this paper
• Early identification of subjective cognitive functional decline among patients with Parkinson’s disease: a longitudinal pilot study

  2022cites this paper
• REM sleep behavioral disorder may be an independent risk factor for orthostatic hypotension in Parkinson’s disease

  2021cites this paper
• Dopamine depletion and subcortical dysfunction disrupt cortical synchronization and metastability affecting cognitive function in Parkinson's disease

  2021cites this paper
• What Do We Know about Theory of Mind Impairment in Parkinson’s Disease?

  2021cites this paper
• Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's disease.

  2021cites this paper
• Brain connectivity markers in advanced Parkinson’s disease for predicting mild cognitive impairment

  2021cites this paper
• Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson's disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysis.

  2021cites this paper
• The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease

  2021cites this paper
• A Novel Approach for Cognitive Clustering of Parkinsonisms through Affinity Propagation

  2021cites this paper
• Does the Montreal Cognitive Assessment (MoCA) identify cognitive impairment profiles in Parkinson’s disease? An exploratory study

  2021cites this paper
• Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes

  2020cites this paper
• Test the Best: Classification Accuracies of Four Cognitive Rating Scales for Parkinson's Disease Mild Cognitive Impairment.

  2020cites this paper
• Direct and indirect assessment of functional abilities in patients with Parkinson’s disease transitioning to dementia

  2020cites this paper
• REM Sleep Behavior Disorder in Parkinson’s Disease: Effects on Cognitive, Psychiatric, and Functional outcomes

  2020cites this paper
• Treatment of Nonmotor Symptoms Associated with Parkinson Disease.

  2020cites this paper
• Cognition Deficits in Parkinson's Disease: Mechanisms and Treatment

  2020cites this paper
• Cognitive Impairment and Dementia in Parkinson Disease.

  2020cites this paper
• Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies

  2020cites this paper
• An Expert Consensus Study on the Validity of Card Games to Assess Mild Cognitive Impairment (Preprint)

  2020cites this paper
• Cognitive reserve, individual alpha frequency in Parkinson’s disease

  2020cites this paper
• A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy

  2020cites this paper
• Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.

  2020cites this paper
• Clinically assessing cognitive function in Parkinson's disease

  2020cites this paper
• Dissecting Digital Card Games to Yield Digital Biomarkers for the Assessment of Mild Cognitive Impairment: Methodological Approach and Exploratory Study

  2020cites this paper
• Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis

  2019cites this paper
• Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease

  2019cites this paper
• Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies

  2019cites this paper
• Motor fluctuations and psychological distress in Parkinson's disease.

  2019cites this paper
• Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta‐analysis of prospective cohort studies

  2019cites this paper
• Subjective cognitive decline and progression to dementia in Parkinson’s disease: a long-term follow-up study

  2019cites this paper
• Structural and functional MRI changes associated with cognitive impairment and dementia in

  2019cites this paper
• Neuroimaging biomarkers differentiate Parkinson disease with and without cognitive impairment and dementia

  2019cites this paper
• Clinical utility of the INECO Frontal Screening for detecting Mild Cognitive Impairment in Parkinson’s disease

  2019cites this paper
• Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience

  2019cites this paper
• Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies

  2019cites this paper
• A Predictive Diagnosis for Parkinson’s Disease Through Machine Learning

  2019cites this paper
• Measuring executive dysfunction in Parkinson’s disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E)

  2018cites this paper
• Effects of deep brain stimulation of the subthalamic nucleus and the pedunculopontine nucleus on cognitive function in Parkinson's disease

  2018cites this paper
• Troubles cognitifs légers et maladie de Parkinson

  2018cites this paper
• Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson’s Disease

  2018cites this paper
• World Journal of Psychiatry

  year unknowncites this paper
• NEUROLOGY AND PRECLINICAL

  year unknowncites this paper